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Respiratory disorders are responsible for considerable morbidity, health care utilisation, societal costs and approximately one in five deaths worldwide [1-4]. Yet, despite this substantial health and societal burden – which particularly affects the world’s poorest populations and as such is a 
major contributor to global health inequalities – respiratory disorders have historically not received the 
policy priority they warrant. For example, despite causing an estimated 1000 deaths per day, less than 
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half of the world’s countries collect data on asthma prevalence (http://www.globalasthmareport.org/). This 
is true for both communicable and non-communicable respiratory disorders, many of which are either 
amenable to treatment or preventable.
Part of the reason for this has been competing donor priorities leading to a focus on other conditions such 
as HIV, with a relative neglect of non-communicable lung diseases and of environmental determinants of 
lung disease. We hope that the launch of the UK’s Global Health Respiratory Network (GHRN; Figure 1) 
represents a change in approach, at least in the UK. 
Central to the strength of this Network is bringing to-
gether experts across the full range of respiratory 
health disciplines, including social, health, clinical 
and biomedical sciences as well as laboratory-based, 
clinical, implementation and health systems research, 
in non-communicable respiratory disorders (eg, asth-
ma, chronic obstructive pulmonary disease [COPD]), 
communicable respiratory diseases (eg, tuberculosis 
[TB], pneumonia), and lung health (public health) to 
work collaboratively and synergistically, rather than 
competitively. It also brings those working in public 
health, primary care, secondary care (paediatrics and 
adult) and palliative care together, looking at respira-
tory diseases through a system-wide scope to – most 
importantly – lead to improvements in the respira-
tory health of the world’s poorest people.
Following the 2015 decision of the UK Government to channel £1.5 billion of the Official Development 
Assistance (ODA) budget through UK Research and Innovation (UKRI)[5], there was an open call for 
proposals from the UK’s National Institute for Health Research (NIHR) to establish Global Health Research 
Groups and Units [https://www.nihr.ac.uk/explore-nihr/funding-programmes/global-health/]. Groups 
would represent new partnerships between UK and low- and middle-income country (LMIC) partners, 
and Units would be for existing UK-LMIC partnerships to scale-up their work. Both have strong, equi-
table north-south partnerships that focus on addressing the needs of the poorest populations in hitherto 
neglected disease areas. In response to this NIHR initiative, and a related Global Challenges Research 
Fund (GCRF) programme from UKRI, a number of proposals with a focus on, or including, respiratory 
health were successful, as summarised in Table 1.
This has created a cohort of UK-funded Southern-facing research collaborations with a shared focus not 
only on respiratory related illness, but on capacity building and multidisciplinary research in active part-
nership with LMIC researchers. In recognition of the opportunity to move towards a more collaborative 
model of working, a number of the funded programmes addressing respiratory diseases came together 
with a view to sharing experiences, knowledge, lessons learnt and networks; leading to the formation of 
the GHRN. The core aim of the GHRN is to work collaboratively to improve global respiratory health, 
focusing on the poorest populations of the world. To this end, GHRN members, with funders’ approval, 
agreed to pool resources to create a secretariat.
The UK arm of the GHRN has met both virtually and in-person to share ideas and establish initial priorities 
for work over the short- to medium-term. This initial list of priorities is summarised in Table 2. More fun-
damentally, we have sought to develop respectful, trusting relationships between the scientific and manage-
ment leadership teams of these various initiatives that enable collaborative sharing and learning. Examples 
have included supporting ethics and regulatory approvals for overseas studies where a suitable infrastructure 
does not exist in an institution, sharing experiences in relation to good financial grant practice, and identi-
fying additional networks through which pathways to impact can be accelerated and amplified.
Whilst it is still early days for the GHRN, we are pleased to see that our collaborative approach has been 
welcomed by our funders and, as such, other Units and Groups are being recommended to consider this 
approach. We hope that this will lead to researchers in other disease areas following suit to seek out syn-
ergies that can accelerate collaborative global working in their respective fields.
Figure 1. Members of the GHRN at the inaugural meeting in 
Edinburgh, 2018.
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Although encouraged by the opportunities for working together, there are of course challenges. For ex-
ample, within the limited resources available, we are grappling with how best to ensure that researchers 
based in LMICs are able to lead and shape this collaboration. Building on the equitable partnerships de-
veloped and nurtured as part of these initiatives, we are looking into the practicalities of using web-based 
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Table 1. Global health initiatives participating in the GHRN
Unit/GroUp/project Lead UK orGanisation partner coUntries
NIHR Global Health Research Unit on Respiratory Health (RESPIRE);  
www.ed.ac.uk/usher/respire
University of 
Edinburgh
Bangladesh, India, Malaysia, Pakistan
NIHR Global Health Research Unit on Lung Health and TB in Africa 
(IMPALA); www.lstmed.ac.uk/impala
Liverpool School of 
Tropical Medicine
Cameroon, Ethiopia, Ghana, Kenya, Malawi, 
Nigeria, South Africa, Sudan, Tanzania, Uganda
NIHR Global Health Research Unit on Mucosal Pathogens (MPRU);  
www.mpru.org/research
University College 
London
Ghana, Kenya, Malawi, Mali, South Africa, The 
Gambia, Uganda
NIHR Global Health Research Group on Social Policy and Health  
Inequalities; www.gla.ac.uk/sphi
University of Glasgow Brazil
NIHR Global Health Research Group on Global COPD in Primary Care  
(Breathe Well)
www.birmingham.ac.uk/research/activity/applied-health/research/breathe-well
University of 
Birmingham
Brazil, China, Republic of North Macedonia, 
Georgia
NIHR Global Health Research Group on Achieving Control of Asthma in 
Children In Africa (ACACIA); https://www.acacia-asthma.org
Queen Mary 
University of London
Ghana, Malawi, Nigeria, South Africa, Uganda, 
Zimbabwe
NIHR Global Health Research Group on Addressing Smokeless Tobacco 
and building Research capacity in South Asia (ASTRA);  
www.york.ac.uk/igdc/research/astra-project
University of York Bangladesh, India, Pakistan
NIHR Global Health Research Group on Respiratory Rehabilitation 
(Global RECHARGE); https://www.leicesterbrc.nihr.ac.uk/themes/respiratory/
research/global-recharge
University of Leicester India, Kyrgyzstan, Sri Lanka, Uganda
NIHR Global Health Research Group on Asthma Attacks Causes and 
Prevention Study in Urban Latin America (ATTACK); www.sgul.ac.uk
St George's, 
University of London
Brazil, Ecuador
UKRI GCRF: A mathematical modelling framework for tuberculosis 
burden estimation and economic evaluation of pharmaceutical 
interventions
University of Sheffield Malawi, South Africa, Zambia
UKRI GCRF: Tobacco Control Capacity Programme (TCCP);  
http://ghpu.sps.ed.ac.uk/gcrf-tccp
University of 
Edinburgh
Bangladesh, Ethiopia, India, Ghana, Pakistan, 
South Africa, The Gambia, Uganda
COPD – chronic obstructive pulmonary disease, GHRN – Global Health Respiratory Network, NIHR – National Institute for Health Research
Table 2. Agreed initial priorities for the GHRN
deLiverabLe initiaL prioritisation
Map and describe briefly each partner’s relevant research - provide the baseline. High
Include categories such as: Countries, respiratory category (eg, tobacco dependence, asthma, COPD, pneumonia, TB); study design 
(eg, RCT, cross-sectional study), what inequalities are being considered (eg, gender, income, employment), cross-cutting themes.
Heat map showing intensity of GHRN research activity overlaid on burden of respiratory diseases (prevalence and DALYs of lower 
respiratory infections, asthma, COPD, TB, lung cancer).
High
Heat map showing intensity of research activity compared to burden of: a) respiratory diseases; and b) key behavioural and envi-
ronmental exposures, including tobacco dependence, indoor air pollution and outdoor air pollution.
High
Summary of capacity building initiatives, including but not limited to, training resources available eg, spirometry, patient and pub-
lic involvement, qualitative research, stakeholder mapping.
High
Register of data sets created by the Groups/Units that could be used in further studies. High
Programme of high-level engagement opportunities. High
Develop a national networking event to agree research ideas to address knowledge gaps identified by mapping and by policymakers. High
Map health inequalities: ideally the burden faced by the poorest in society in each country which, seen alongside the GBD maps, 
would show where the effort needs to be concentrated.
Medium
Initially - scope what data exist and in which countries.
Analysis of policy and engagement activities with policy influencers eg, parliamentarians, civil servants, non-governmental organ-
isations, international agencies; other effective advocacy organisations and individuals – with the aim to identify areas of harmoni-
sation, gaps, key messages, to facilitate joint planning and working.
Medium
Summary of tools used to engage policymakers and policy influencers eg, mapping tools, tools to analyse enablers and barriers, 
successful engagement activities and their costs, success stories, policy briefs, fact sheets, infographics, links to promotional videos.
Medium
Coordinate submissions for one or two collaborative commentaries. Medium
Proposals for joint symposia/workshops at upcoming conferences. Medium
Intelligence gathering to make the most of existing opportunities for networking for PhD students across the Consortium. Review – 3 
monthly
DALYs – disability-adjusted life-years, RCT – randomised controlled trial, TB – tuberculosis
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platforms to facilitate real-time engagement across our Network; this is not straightforward as we have 
yet to identify a platform that works across all countries and there are also the logistical and financial chal-
lenges of organising simultaneous interpreting facilities across multiple languages. However, we are con-
fident that by working together we can greatly increase our ability to overcome these challenges.
Looking ahead, we see tremendous opportunities from joined-up working. Ours is most definitely an 
open model of collaboration that will, we hope, see the GHRN grow in the coming years. We aspire, with 
continuing support beyond the initial 2017-21 first term for these collaborations, for our Network to de-
velop an online knowledge hub on respiratory diseases and a growing cohort of GHRN-fellows/GHRN-
scholars. We encourage those interested in working with us, whether in the UK or internationally, to join 
our Network to improve the respiratory health of the world’s poorest populations.
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